Commonwealth Equity Services, LLC Cassava Sciences Inc Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 119,431 shares of SAVA stock, worth $287,828. This represents 0.01% of its overall portfolio holdings.

Number of Shares

119,431

Previous 48,451 146.5%

Holding current value

$287,828

Previous $598,000 487.79%

% of portfolio

0.01%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$9.57 - $35.08 $679,278 - $2.49 Million	70,980 Added 146.5%	119,431 $3.52 Million
Q2 2024 Jul 31, 2024	BUY	$12.35 - $26.11 $41,792 - $88,356	3,384 Added 7.51%	48,451 $598,000
Q1 2024 Apr 29, 2024	BUY	$18.44 - $26.41 $53,863 - $77,143	2,921 Added 6.93%	45,067 $914,000
Q4 2023 Feb 06, 2024	BUY	$12.64 - $30.11 $63,301 - $150,790	5,008 Added 13.48%	42,146 $949,000
Q3 2023 Oct 23, 2023	BUY	$16.64 - $25.32 $79,123 - $120,396	4,755 Added 14.68%	37,138 $618,000
Q2 2023 Aug 10, 2023	BUY	$21.59 - $27.88 $55,637 - $71,846	2,577 Added 8.65%	32,383 $794,000
Q1 2023 May 11, 2023	BUY	$23.46 - $36.44 $149,017 - $231,466	6,352 Added 27.08%	29,806 $718,000
Q4 2022 Feb 07, 2023	BUY	$27.82 - $44.16 $195,964 - $311,063	7,044 Added 42.93%	23,454 $692,000
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $45,462 - $142,151	2,784 Added 20.43%	16,410 $686,000
Q2 2022 Jul 19, 2022	BUY	$17.22 - $38.47 $12,725 - $28,429	739 Added 5.73%	13,626 $383,000
Q1 2022 May 04, 2022	BUY	$32.6 - $53.05 $34,784 - $56,604	1,067 Added 9.03%	12,887 $478,000
Q4 2021 Jan 31, 2022	BUY	$36.77 - $90.91 $43,940 - $108,637	1,195 Added 11.25%	11,820 $516,000
Q3 2021 Oct 29, 2021	SELL	$41.79 - $135.3 $192,526 - $623,327	-4,607 Reduced 30.25%	10,625 $659,000
Q2 2021 Aug 11, 2021	BUY	$32.15 - $89.72 $179,525 - $500,996	5,584 Added 57.88%	15,232 $1.3 Million
Q1 2021 May 04, 2021	BUY	$7.09 - $87.95 $68,404 - $848,541	9,648 New	9,648 $433,000

Others Institutions Holding SAVA

# of Institutions

207

Shares Held

14M

Call Options Held

2.98M

Put Options Held

6.57M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $96.6M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Cassava Sciences Inc Transaction History